Cover Image
市場調查報告書

呼吸輔助設備的全球市場:醫療設備的開發平台評估

Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 361020
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
呼吸輔助設備的全球市場:醫療設備的開發平台評估 Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月01日 內容資訊: 英文 79 Pages
簡介

本報告提供全球呼吸輔助配件市場上主要的開發中產品與其臨床實驗的進展調查,彙整產品功能、特性比較分析 (臨床實驗的各進行階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 呼吸輔助設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各部門
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 呼吸輔助設備的企業:各臨床實驗階段的開發中產品
  • 呼吸輔助設備:各臨床實驗階段的開發中產品

第5章 呼吸輔助設備市場:企業·產品概要

  • ALung Technologies, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Breethe, Inc.
  • Case Western Reserve University
  • Haemair Limited
  • Liberate Medical, LLC
  • Lung Biotechnology PBC
  • McGowan Institute for Regenerative Medicine
  • MedArray Inc.
  • Merit Medical Systems, Inc.
  • Michigan Critical Care Consultants, Inc.
  • Miromatrix Medical Inc.
  • Pneumedicare Ltd.
  • Rice University
  • The Charles Stark Draper Laboratory Inc
  • University of Arizona
  • University of California, Los Angeles
  • University of California, San Francisco
  • University of Kansas
  • University of Pittsburgh
  • Xenios AG

第6章 縫合線市場:目前的趨勢 (全20件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report,"Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Respiratory Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Respiratory Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Respiratory Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Respiratory Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Respiratory Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Respiratory Assist Devices Overview

3. Products under Development

  • 3.1. Respiratory Assist Devices - Pipeline Products by Stage of Development
  • 3.2. Respiratory Assist Devices - Pipeline Products by Segment
  • 3.3. Respiratory Assist Devices - Pipeline Products by Territory
  • 3.4. Respiratory Assist Devices - Pipeline Products by Regulatory Path
  • 3.5. Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
  • 3.6. Respiratory Assist Devices - Ongoing Clinical Trials

4. Respiratory Assist Devices - Pipeline Products under Development by Companies

  • 4.1. Respiratory Assist Devices Companies - Pipeline Products by Stage of Development
  • 4.2. Respiratory Assist Devices - Pipeline Products by Stage of Development

5. Respiratory Assist Devices Companies and Product Overview

  • 5.1. ALung Technologies Inc Company Overview
    • 5.1.1. ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Breethe, Inc. Company Overview
    • 5.2.1. Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Case Western Reserve University Company Overview
    • 5.3.1. Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Haemair Ltd Company Overview
    • 5.4.1. Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Liberate Medical, LLC Company Overview
    • 5.5.1. Liberate Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Lung Biotechnology PBC Company Overview
    • 5.6.1. Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. McGowan Institute for Regenerative Medicine Company Overview
    • 5.7.1. McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. MedArray Inc. Company Overview
    • 5.8.1. MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Merit Medical Systems, Inc. Company Overview
    • 5.9.1. Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Michigan Critical Care Consultants, Inc. Company Overview
    • 5.10.1. Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Miromatrix Medical Inc Company Overview
    • 5.11.1. Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Pneumedicare Ltd. Company Overview
    • 5.12.1. Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Rice University Company Overview
    • 5.13.1. Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. The Charles Stark Draper Laboratory Inc Company Overview
    • 5.14.1. The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. University of Arizona Company Overview
    • 5.15.1. University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. University of California Los Angeles Company Overview
    • 5.16.1. University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. University of California San Francisco Company Overview
    • 5.17.1. University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. University of Kansas Company Overview
    • 5.18.1. University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. University of Pittsburgh Company Overview
    • 5.19.1. University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Xenios AG Company Overview
    • 5.20.1. Xenios AG Pipeline Products & Ongoing Clinical Trials Overview

6. Respiratory Assist Devices- Recent Developments

  • 6.1. May 11, 2017: Capnia Provides Corporate Update and Reports First Quarter 2017 Financial Results
  • 6.2. May 09, 2017: Inogen Announces First Quarter 2017 Financial Results
  • 6.3. May 04, 2017: Teleflex Reports First Quarter 2017 Results
  • 6.4. Apr 25, 2017: ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS
  • 6.5. Mar 15, 2017: Capnia Reports Fourth Quarter and Full Year 2016 Financial Results
  • 6.6. Mar 07, 2017: MGC Diagnostics Reports Fiscal 2017 First Quarter Results
  • 6.7. Feb 28, 2017: Inogen Announces Fourth Quarter and Full Year 2016 Financial Results and Updates 2017 Guidance
  • 6.8. Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer
  • 6.9. Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance
  • 6.10. Jan 25, 2017: MGC Diagnostics Reports Fiscal 2016 Fourth Quarter and Year End Results
  • 6.11. Dec 06, 2016: Inogen appoints new president and CEO
  • 6.12. Nov 14, 2016: Capnia Reports Third Quarter 2016 Financial Results
  • 6.13. Nov 03, 2016: Inogen Announces Third Quarter 2016 Financial Results
  • 6.14. Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results
  • 6.15. Sep 07, 2016: Merit Medical Receives 510(K) Clearance for the Elation Pulmonary Dilation Balloon
  • 6.16. Sep 07, 2016: MGC Diagnostics Reports Fiscal 2016 Third Quarter Results
  • 6.17. Aug 12, 2016: Capnia Reports Second Quarter 2016 Financial Results
  • 6.18. Aug 04, 2016: Inogen Announces Second Quarter 2016 Financial Results
  • 6.19. Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results
  • 6.20. Jul 14, 2016: MGC Diagnostics Forms Distinguished Scientific Advisory Committee

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Respiratory Assist Devices - Pipeline Products by Stage of Development
  • Table 2: Respiratory Assist Devices - Pipeline Products by Segment
  • Table 3: Respiratory Assist Devices - Pipeline Products by Territory
  • Table 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path
  • Table 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Respiratory Assist Devices - Ongoing Clinical Trials
  • Table 7: Respiratory Assist Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Respiratory Assist Devices - Pipeline Products by Stage of Development
  • Table 9: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Hattler Catheter - Product Status
  • Table 11: Hattler Catheter - Product Description
  • Table 12: Hemolung RAS - Product Status
  • Table 13: Hemolung RAS - Product Description
  • Table 14: ALung Technologies Inc - Ongoing Clinical Trials Overview
  • Table 15: Hemolung RAS - A Pivotal Clinical Study of Hemolung Respiratory Assist System in Treatment of Patients with Chronic Obstructive Pulmonary Disease
  • Table 16: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD
  • Table 17: Hemolung RAS - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation
  • Table 18: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure
  • Table 19: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: OXY-1 - Product Status
  • Table 21: OXY-1 - Product Description
  • Table 22: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Portable Artificial Lung - Product Status
  • Table 24: Portable Artificial Lung - Product Description
  • Table 25: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Blood/Air Mass Exchanger - Product Status
  • Table 27: Blood/Air Mass Exchanger - Product Description
  • Table 28: Liberate Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Non-invasive Electrical Stimulator - Product Status
  • Table 30: Non-invasive Electrical Stimulator - Product Description
  • Table 31: VentFree - Product Status
  • Table 32: VentFree - Product Description
  • Table 33: Liberate Medical, LLC - Ongoing Clinical Trials Overview
  • Table 34: VentFree - VentFree: A Novel Abdominal Stimulator to Assist With Ventilator Weaning
  • Table 35: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Implantable Artificial Lung - Product Status
  • Table 37: Implantable Artificial Lung - Product Description
  • Table 38: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Biohybrid Artificial Lung - Product Status
  • Table 40: Biohybrid Artificial Lung - Product Description
  • Table 41: Chronic Artificial Lung - Product Status
  • Table 42: Chronic Artificial Lung - Product Description
  • Table 43: Impeller Percutaneous Respiratory Assist Catheter (iPRAC) - Product Status
  • Table 44: Impeller Percutaneous Respiratory Assist Catheter (iPRAC) - Product Description
  • Table 45: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Artificial Lung Fiber - Product Status
  • Table 47: Artificial Lung Fiber - Product Description
  • Table 48: Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Elation Pulmonary Balloon Dilation Catheter - Product Status
  • Table 50: Elation Pulmonary Balloon Dilation Catheter - Product Description
  • Table 51: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: BioLung - Product Status
  • Table 53: BioLung - Product Description
  • Table 54: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Miromatrix Artificial Lung - Product Status
  • Table 56: Miromatrix Artificial Lung - Product Description
  • Table 57: Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Pneumonitor - Product Status
  • Table 59: Pneumonitor - Product Description
  • Table 60: Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Respiratory Assist Device - Product Status
  • Table 62: Respiratory Assist Device - Product Description
  • Table 63: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Silicone-Based Microfluidic Artificial Lung - Product Status
  • Table 65: Silicone-Based Microfluidic Artificial Lung - Product Description
  • Table 66: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Respiratory Assist Device - Product Status
  • Table 68: Respiratory Assist Device - Product Description
  • Table 69: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Percutaneous Catheter for Lung Assist Device - Product Status
  • Table 71: Percutaneous Catheter for Lung Assist Device - Product Description
  • Table 72: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Neonatal ECMO Device - Product Status
  • Table 74: Neonatal ECMO Device - Product Description
  • Table 75: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: VestibuGLIDE System - Product Status
  • Table 77: VestibuGLIDE System - Product Description
  • Table 78: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Paracorporeal Ambulatory Assist Lung - Product Status
  • Table 80: Paracorporeal Ambulatory Assist Lung - Product Description
  • Table 81: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: i-lung - Product Status
  • Table 83: i-lung - Product Description
  • Table 84: Xtralung - Product Status
  • Table 85: Xtralung - Product Description
  • Table 86: Glossary

List of Figures

  • Figure 1: Respiratory Assist Devices - Pipeline Products by Stage of Development
  • Figure 2: Respiratory Assist Devices - Pipeline Products by Segment
  • Figure 3: Respiratory Assist Devices - Pipeline Products by Territory
  • Figure 4:
Back to Top